Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report) was upgraded by Wall Street Zen from a “strong sell” rating to a “sell” rating in a research report issued on Sunday. Several other analysts also recently issued reports on ZNTL. Wells Fargo & Company began coverage on Zentalis Pharmaceuticals in a research note on Tuesday, March 17th. [...]
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Upgraded by Wall Street Zen to “Sell” Rating
